Search results for "Highlights"


 
Results 21 - 30 of about 315 for "Highlights".

Weekly GLP-1 analogue associated with reduced MI, stroke risk, industry study finds | ACP Diabetes Monthly

The trial of semaglutide included 3,297 patients with type 2 diabetes, 83% of whom had established cardiovascular disease, chronic kidney disease, or both.

Minority of patients with type 1 diabetes achieve ADA goals for glycemic control, study finds | ACP Diabetes Monthly

Despite increasing adoption of insulin pumps and continuous glucose monitors, control of HbA1c hasn't necessarily improved, the authors noted.

Drug-eluting stents may not confer advantage in diabetic patients | ACP Diabetes Monthly

An editorial noted that drug-eluting stents may work for noncomplex lesions in patients with diabetes, but complex disease states incurred high rates of myocardial infarction and revascularization.

Cardiovascular event rates similar among newer second-line medications for type 2 diabetes | ACP Diabetes Monthly

The comparison of dipeptidyl peptidase-4 inhibitors with other drug classes did find higher rates of major adverse cardiovascular events with basal insulin, sulfonylureas, and meglitinides than with the newer drugs.

SGLT2 inhibitors associated with increased risk of amputations, diabetic ketoacidosis | ACP Diabetes Monthly

Sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 receptor agonists had similar rates of other adverse events, including bone fracture, acute kidney injury, serious urinary tract infection, venous thromboembolism, and

Trial finds improvement in HbA1c level with intensive periodontal treatment | ACP Diabetes Monthly

Intensive treatment consisted of whole-mouth subgingival scaling, surgical periodontal therapy if patients practiced good oral hygiene or dental cleaning if they did not, and supportive periodontal therapy every three months until the end of the

March 10, 2017 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

December 8, 2017 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

October 7, 2016 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

June 13, 2014 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next